Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiao-Ming Hou, Zulqarnain Baloch, Zhan-Hong Zheng, Wen-Hui Zhang, Ying Feng, Duan-Duan Li, Xin-An Wu & Shi-Hua Yang. (2019) Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer. Cancer Management and Research 11, pages 3275-3283.
Read now
Read now
Yu Ma, Xuena Li, Song Chen, Bulin Du & Yaming Li. (2019) MicroRNA-4458 suppresses migration and epithelial–mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells. Cancer Management and Research 11, pages 637-649.
Read now
Read now
Articles from other publishers (16)
Shaofei Cheng, Fengying Qian, Qin Huang, Lirong Wei, Yawen Fu & Yuzhen Du. (2018) HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells. Cell Death & Disease 9:5.
Crossref
Crossref
Marcel P. Stoop, Sabine Visser, Evert van Dijk, Joachim G.J.V. Aerts, Bruno H. Stricker & Theo M. Luider. (2016) A new quantification method for assessing plasma concentrations of pemetrexed and its polyglutamate metabolites. Journal of Pharmaceutical and Biomedical Analysis 128, pages 1-8.
Crossref
Crossref
Rui Hu, Fengqing Hu, Xiao Xie, Lei Wang, Guoqing Li, Tong Qiao, Mingsong Wang & Haibo Xiao. (2016) TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells. Tumor Biology 37:9, pages 12181-12191.
Crossref
Crossref
Xiaolin Wang, Weiping Shi, Hongcan Shi, Shichun Lu, Kang Wang, Chao Sun, Jiansheng He, Weiguo Jin, Xiaoxia Lv, Hui Zou & Yusheng Shu. (2016) RETRACTED ARTICLE: TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Athanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, Despoina Aggouraki, Eleftheria Kleio Dermitzaki, Dora Hatzidaki, Nikolaos Kentepozidis, Dimitris Mavroudis & Vassilis Georgoulias. (2014) A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide. Lung Cancer 86:1, pages 59-66.
Crossref
Crossref
Zhuang Yu, Xiu-Mei Li, Shi-Hai Liu, Bing Liu, Cai-Hong Gao & Xin Hou. (2014) Downregulation of both EGFR and ErbB3 improves the cellular response to pemetrexed in an established pemetrexed‑resistant lung adenocarcinoma A549 cell line. Oncology Reports.
Crossref
Crossref
Xiaojing Wu, Yuquan Zhang, Changjun Min, Siwei Zhu, Jie Feng & X-C Yuan. (2013) Dynamic optical tweezers based assay for monitoring early drug resistance. Laser Physics Letters 10:6, pages 065604.
Crossref
Crossref
Yujia Wen, Eric R. Gamazon, Wasim K. Bleibel, Claudia Wing, Shuangli Mi, Bridget E. McIlwee, Shannon M. Delaney, Shiwei Duan, Hae Kyung Im & M. Eileen Dolan. (2012) An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers. Human Molecular Genetics 21:7, pages 1470-1480.
Crossref
Crossref
Jun Hou, Margaretha Lambers, Bianca den Hamer, Michael A. den Bakker, Henk C. Hoogsteden, Frank Grosveld, Joost Hegmans, Joachim Aerts & Sjaak Philipsen. (2012) Expression Profiling-Based Subtyping Identifies Novel Non-small Cell Lung Cancer Subgroups and Implicates Putative Resistance to Pemetrexed Therapy. Journal of Thoracic Oncology 7:1, pages 105-114.
Crossref
Crossref
Chunyan Hu, Hui Lv, Guoqing Pan, Huiqiu Cao, Zhenghao Deng, Chuanyu Hu, Jifang Wen & Jianhua Zhou. (2011) The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma. International Journal of Experimental Pathology 92:5, pages 333-339.
Crossref
Crossref
Athanasios Kotsakis, Sophia Agelaki, Nikolaos Vardakis, George Stathopoulos, Lambros Vamvakas, Antonia Kalykaki, Nikolaos Kentepozidis, Emmanouel Kontopodis, Georgia Sfakiotaki, Dimitris Mavroudis & Vassilis Georgoulias. (2010) A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology 68:2, pages 415-422.
Crossref
Crossref
Jordan P. Volpato, Nadine Mayotte, Elena Fossati, Vanessa Guerrero, Guy Sauvageau & Joelle N. Pelletier. (2011) Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells. Journal of Molecular Recognition 24:2, pages 188-198.
Crossref
Crossref
Ming-Fang Wu, Yi-Min Hsiao, Chuan-Fu Huang, Yu-Hsin Huang, Wan-Jung Yang, Hsiu-Wen Chan, Jinghua Tsai Chang & Jiunn-Liang Ko. (2010) Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non-small Cell Lung Cancer Cells. Journal of Thoracic Oncology 5:8, pages 1143-1151.
Crossref
Crossref
Wang Rui, Feng Bing, Song Hai-Zhu, De Wei & Chen Long-Bang. (2010) Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). Journal of Cellular and Molecular Medicine 14:1-2, pages 206-214.
Crossref
Crossref
Noah M. Hahn, Thomas Powles & Christopher J. Sweeney. (2009) Development of novel agents for bladder cancer. Update on Cancer Therapeutics 3:4, pages 160-169.
Crossref
Crossref
Joseph R. Bertino. (2008) Transfer of Drug Resistance Genes into Hematopoietic Stem Cells for Marrow Protection. The Oncologist 13:10, pages 1036-1042.
Crossref
Crossref